Cargando…

Antifibrotic in interstitial lung diseases: When, where, and how long?

Detalles Bibliográficos
Autores principales:	Rai, Deependra K., Tripathi, Suryakant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746283/ https://www.ncbi.nlm.nih.gov/pubmed/36629226 http://dx.doi.org/10.4103/lungindia.lungindia_283_22

Ejemplares similares

The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease
por: Liang, Minrui, et al.
Publicado: (2022)

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease
por: Boleto, Gonçalo, et al.
Publicado: (2022)

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
por: Wilfong, Erin M., et al.
Publicado: (2021)

Key Hole Craniotomy: When, Where, and How to Apply?
por: Amirjamshidi, A.
Publicado: (2019)

Differences in the Evolution of Lung Function Before and After Treatment With Antifibrotics in Patients With Interstitial Lung Disease
por: Liendo-Martínez, Katiuska Herminia, et al.
Publicado: (2023)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
por: Dsouza, Kevin G., et al.
Publicado: (2023)

When to start and when to stop antifibrotic therapies
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2017)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

The Role of Surgical Lung Biopsy in Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
por: Limper, Andrew H.
Publicado: (2019)

RNA Sequencing Uncovers Antifibrotic Genes during Lung Fibrosis Resolution
por: Han, Hongwei, et al.
Publicado: (2021)

Navigating the who, where, what, when, how and why of trauma exposure and response
por: Vallières, Frédérique, et al.
Publicado: (2021)

Aiming for the end of the COVID-19 pandemic: the what, how, who, where, and when
por: Soriano, Joan B., et al.
Publicado: (2023)

“Yap”-ing about the Antifibrotic Benefits of Prostacyclin
por: Huang, Steven K.
Publicado: (2019)

Antidotes: Where are they when needed?
por: Batmanabane, Gitanjali
Publicado: (2014)

The Treatment of Aortic Valve Stenosis in Intermediate and Low-Risk Patients—When, How and Where
por: Ribichini, Flavio L., et al.
Publicado: (2022)

Influence of Scribble polarity complex on hematopoiesis and leukemia – a matter of where, when and how
por: Heidel, Florian H., et al.
Publicado: (2018)

Soldiering on the Job When Ill: Productivity Costs in Connective Tissue Disease–associated Interstitial Lung Disease
por: Fernández Pérez, Evans R.
Publicado: (2020)

Astrocytogenesis: where, when, and how
por: Akdemir, Ekin Su, et al.
Publicado: (2020)

Who, when, where, how!
Publicado: (1960)

Broad Adoption of Antifibrotics in Idiopathic Pulmonary Fibrosis: Still a Long Way to Go
por: Assayag, Deborah
Publicado: (2021)

From the Gut to the Lung: Evidence of Antifibrotic Activity of Endocrine Fibroblast Growth Factor 19
por: Guzy, Robert D., et al.
Publicado: (2022)

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
por: Sugino, Keishi, et al.
Publicado: (2021)

Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family
por: Estrella, Deborah dos Reis, et al.
Publicado: (2021)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
por: Erre, Gian Luca, et al.
Publicado: (2021)

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
por: Cottin, Vincent
Publicado: (2019)

Impact of Antifibrotic Treatment on Postoperative Complications in Patients with Interstitial Lung Diseases Undergoing Lung Transplantation: A Systematic Review and Meta-Analysis
por: Taweesedt, Pahnwat, et al.
Publicado: (2023)

The when, where, and how of environmental hazards.
Publicado: (1999)

Limb salvage: When, where, and how?
por: Puri, Ajay
Publicado: (2015)

Origin of the retroviruses: when, where, and how?
por: Hayward, Alexander
Publicado: (2017)

Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

From here…… where and how?
por: Gopikrishna, Velayutham
Publicado: (2009)

PET/CT and interstitial lung disease
por: Sawamura, Marcio Valente Yamada, et al.
Publicado: (2022)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2016)

Current Developments in Interstitial Lung Disease
por: Mori, Shunsuke, et al.
Publicado: (2016)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2018)

Cryobiopsy for Interstitial Lung Disease: The Heat Is On
por: Raghu, Ganesh, et al.
Publicado: (2019)

The Bloom Is in Bud for Interstitial Lung Diseases
por: Noth, Imre, et al.
Publicado: (2020)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kkhliogv1rgp6g2sivs5d1n9p7